Table 4 Choices of treatment and comorbidity for IBD patients from 1980 until 2018
Characteristics | Ulcerative Colitis N = 281 | Crohn’s Disease N = 132 |
|---|---|---|
Treatment, n (%) | ||
5-ASA | 264 (94) | 40 (30) |
Immunomodulator | 74 (26) | 82 (62) |
Azathioprine | 73 | 80 |
Mercaptopurine (6-MP) | 1 | 2 |
Steroid | 7 (4.7) | 8 (11.4) |
Biologics | 10 (3.6) | 36 (27.3) |
Adalimumab | 0 | 16 |
Infliximab | 9 | 16 |
Golimumab | 1 | 0 |
Ustekinumab | 0 | 1 |
Vedolizumab | 0 | 3 |
Curcumin extract | 0 | 1 |
No treatment | 9 (3.2) | 4 (3.0) |
Surgery, n (%) | 11 (3.9%) | 46 (34.8) |
Panproctocolectomy + ileostomy | 10 | N/A |
Ileorectal anastomotic resection + ileostomy | 1 | N/A |
Right hemicolectomy | N/A | 10 |
Total colectomy | N/A | 3 |
Right limited hemicolectomy | NA | 4 |
Right transverse colostomy | N/A | 2 |
Segmental colectomy | N/A | 1 |
Small bowel resection | N/A | 8 |
Incision and drainage for fistula | N/A | 8 |
Seton insertion for fistula | N/A | 13 |
Major Comorbidity, n (%) | ||
Type 2 Diabetes Mellitus | 50 (17.8) | 6 (4.5) |
Hypertension | 39 (13.9) | 12 (9.1) |
Dyslipidemia | 32 (11.4) | 2 (1.5) |
Ischemic Heart Disease | 8 (2.8) | 1 (0.7) |
Asthma | 7 (2.5) | 2 (1.5) |
Chronic kidney disease | 2 (0.7) | 1 (0.7) |